» Articles » PMID: 9461566

Identification of Substrates and Regulators of the Mitogen-activated Protein Kinase ERK5 Using Chimeric Protein Kinases

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Mar 28
PMID 9461566
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular signal-regulated protein kinase 5 (ERK5) is a recently discovered orphan mitogen-activated protein kinase for which no substrates or strong activators have been described. Two ERK5 chimeras were created as a novel approach to discover its substrates and upstream regulators. One chimeric protein contained the N-terminal domain of the ERK5 catalytic core (subdomains I-IV) and the C-terminal domain of the ERK2 catalytic core (subdomains V-XI). This chimera was highly responsive to stimuli that regulate ERK2 in vitro and in cells. A second chimeric protein consisted of the N-terminal domain of ERK2 (subdomains I-IV) and the C-terminal domain of the ERK5 catalytic core (subdomains V-XI). This chimera was activated in bacteria by coexpression with a constitutively active mutant of MEK1. Using the activated chimera, we identified three in vitro substrates of ERK5. Assaying ERK5 activity in immune complexes with one of these substrates, c-Myc, we determined that the ERK5 catalytic domain is activated by V12 H-Ras and to a lesser extent by phorbol ester but not by constitutively active mutants of Raf-1. Thus, ERK5 is a target of a novel Ras effector pathway that may communicate with c-Myc.

Citing Articles

ERK5 promotes autocrine expression to sustain mitogenic balance for cell fate specification in human pluripotent stem cells.

Song C, Zhang Z, Leng D, He Z, Wang X, Liu W Stem Cell Reports. 2024; 19(9):1320-1335.

PMID: 39151429 PMC: 11411316. DOI: 10.1016/j.stemcr.2024.07.007.


Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.

Sanchez-Fdez A, Re-Louhau M, Rodriguez-Nunez P, Ludena D, Matilla-Almazan S, Pandiella A NPJ Precis Oncol. 2021; 5(1):78.

PMID: 34404896 PMC: 8371118. DOI: 10.1038/s41698-021-00218-8.


The MEK5/ERK5 Pathway in Health and Disease.

Paudel R, Fusi L, Schmidt M Int J Mol Sci. 2021; 22(14).

PMID: 34299213 PMC: 8303459. DOI: 10.3390/ijms22147594.


Map2k5-Deficient Mice Manifest Phenotypes and Pathological Changes of Dopamine Deficiency in the Central Nervous System.

Huang Y, Wang P, Morales R, Luo Q, Ma J Front Aging Neurosci. 2021; 13:651638.

PMID: 34168549 PMC: 8217467. DOI: 10.3389/fnagi.2021.651638.


Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis.

Giurisato E, Lonardi S, Telfer B, Lussoso S, Risa-Ebri B, Zhang J Cancer Res. 2020; 80(16):3319-3330.

PMID: 32561530 PMC: 7611207. DOI: 10.1158/0008-5472.CAN-19-2416.